Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
作者： Hanshermann Franke , Peter Lennartz
DOI:
关键词:
摘要: The invention relates to pharmaceutical compositions, particularly oral containing an effective content of oxcarbazepine and having a delayed active substance release. compounds have characteristic in-vitro release profile.
lens.org 参考文章(9)
Toshiaki Aono, Photographic element with gas permeable hydrophobic layer on backing layer ,(1992)
Jacques Bourquin, Double-layered oxcarbazepine tablets ,(1994)
Burkhard Schlütermann, Oxacarbazepine film-coated tablets ,(1998)
Steffen Lang, Pharmaceutical compositions comprising oxcarbazepine ,(2000)
Almantas Galvanauskas, Martin E. Fermann, Donald J. Harter, High power fiber chirped pulse amplification systems based on cladding pumped rare-earth doped fibers ,(1995)
George W. Belendiuk, Edward M. Rudnic, Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine ,(1992)
Ifat Katzhendler, Michael Friedman, Zero-order sustained release delivery system for carbamazephine derivatives ,(2000)
Sean Cunningham, Paul Stark, Jagathesan Moodley, Oral morphine multiparticulate formulation ,(1997)
Gary Sackett, Kerry Pacholke, Larry Maher, James Polli, Paul Sheskey, Roll compaction granulation of a controlled-release matrix tablet formulation containing HPMC: Effect of process scale-up on robustness of tablets, tablet stability and predicted in vivo performance Pharmaceutical technology. ,vol. 24, pp. 30- 52 ,(2000)